Apollo Hospitals witnessed a significant block trade worth INR 28.46 crore on the NSE, with each of the 34,036 shares traded exchanging hands at a pricey INR 8,361.50.

Motilal Oswal has identified Apollo Hospitals, Lenskart, and GNG Electronics as strong growth-focused companies to watch. Notably, Apollo Hospitals has shown a significant 13% increase in profits, while Samvardhana Motherson exhibits impressive 55% profit growth. Lenskart also reports a substantial 41% boost in revenues.

Apollo Hospitals has reached its highest stock price in the past year, experiencing a significant 15% increase over the last month. This places it among the top five performing stocks during this period.

Apollo Hospitals has moved from a 'fair' valuation to an 'attractive' one due to increased price appreciation, indicating growing confidence among investors. This shift reflects optimism about the company's growth prospects within the healthcare sector.

Apollo Hospitals intends to launch Apollo HealthCo by December 2026, aiming to establish a vast omnichannel healthcare business worth ₹25,000 crore. As part of the strategic moves, Apollo Cradle & Fertility has been sold to Cloudnine for ₹1,550 crore, while other brands such as Apollo Clinics and Diagnostics remain under their ownership. (Financial Express)

The Sensex experienced a decline of 135 points with the Nifty remaining unchanged, as Bajaj Finance, HUL, and Tech Mahindra led the list of top losers. However, Apollo Hospitals and Honeywell Automation showed growth, while oil stocks climbed due to a drop in Brent crude below $105/barrel.

The demerger of Apollo HealthCo is on track, following the shareholder meeting held on June 24, 2026. Aiming for a Q4 FY27 listing, Apollo HealthCo aspires to achieve an annual revenue of INR 25,000 crores.

Apollo Hospitals predicts significant losses of approximately ₹140-150 crores for their newly established hospitals in the fiscal year. The peak quarterly loss is anticipated to occur during Q2, as suggested by the hospital's management guidance.

Apollo Hospitals has scheduled a virtual creditor meeting for June 24, 2026, to discuss and approve a proposed restructuring plan. Electronic voting will be conducted from June 20-23, 2026, by NSDL as part of this process.

Apollo Hospitals combines Cradle with Cloudnine at a 35x EBITDA multiple, keeping a 9.9% stake, signifying a strategic move to strengthen their focus on maternal care and diagnostics, as stated in the conference call update.

Apollo Hospitals predicts a significant growth of around 15% in healthcare services for the fiscal year 2027, along with an ambition to enhance their profit margins by at least 1%.

Morgan Stanley continues to recommend investing more in LG Electronics, while Goldman Sachs suggests buying shares of Apollo Hospitals. These financial institutions believe these companies have potential for growth.

Nuvama maintains a positive outlook on Apollo Hospitals and boosts their price forecast to INR 9,785, upgrading the previous prediction of INR 9,090. The recommendation remains 'Buy'.

Apollo HealthCo, part of Apollo Hospitals, aims to achieve operational breakeven in Q1 FY2027 as they coordinate this goal with their broader group's restructuring initiatives.

Apollo Hospitals anticipates that their digital health platform, Apollo 24/7, will reach cash breakeven status by the first quarter of FY2027. The company also expects to boost HealthCo margins to a range of 6.5%-7% before the end of this year.

In Q4 of the current fiscal year (FY26), Apollo Hospitals reported a significant 36% increase in profit to ₹529 crore, attributed to robust operational metrics, higher average room occupancy, and improved margins. The company's total revenue for FY26 reached ₹25,229 crore, a 16% growth year-on-year. Notably, Apollo HealthCo turned profitable this fiscal year, benefiting from scale advantages and operational efficiencies.

Apollo Hospitals aims to expand operations and enhance its clinical expertise in order to maintain its leading position within the healthcare sector.

Today, 10 notable companies such as Grasim, Ola Electric, Bosch, and others will release their Q4 results, with a focus on revenue, profit margins, and future outlook by investors. These companies span sectors including healthcare, electric vehicles, infrastructure, and appliances, which can significantly impact the market's overall sentiment.

Apollo Hospitals plans to expand its presence in Gurugram with the addition of 800 beds, aiming for significant growth and revenue increase by 2027.

Investors are advised to consider purchasing shares in Apollo Hospitals, Bosch, and Sammaan Capital due to impressive earnings. The suggested price targets for Apollo range from INR 8325 to 8550, Bosch from INR 37400 to 37800, and Sammaan Cap at around INR 144-148.

Apollo Hospitals' subsidiaries, ASHPL and AFCPL, have reported revenues of Rs 351.5 crore and Rs 100.1 crore respectively. However, both companies are currently operating at a loss, with negative net worths of Rs 153.8 crore for ASHPL and Rs 38.3 crore for AFCPL.

Apollo Hospitals is set to receive a significant boost of 750 crores following the merger with Apollo Fertility, using these funds to enhance its diagnostic and primary healthcare facilities nationwide.

Grasim surpasses expectations in Q4, driven by impressive VSF performance, signaling continued growth potential. Mankind Pharma exhibits strong domestic expansion, while Jubilant Food faces margin challenges. Apollo Hospitals receives mixed reviews due to valuation concerns, but a positive outlook following AB Capital's equity raise.

Apollo Hospitals aims to expand further with the addition of 800 new beds in Gurugram, following a recent increase of 780 beds last fiscal year. However, their profit margins have been affected due to losses at four of their hospitals, which could be mitigated by an anticipated Rs 750 crore from a fertility business merger.

Apollo Hospitals shares will distribute a final dividend of INR 10 per share, as announced by the company. Investors stand to gain from this payout.

Apollo Hospitals has reported strong performance across all its divisions this quarter, as confirmed by the CEO Suneeta Reddy in her recent interview. The company's key growth factors were discussed during this conversation.

Apollo Hospitals anticipates a return of standard profit margins for their hospital operations, as reported by CNBC TV18.

The healthcare provider Apollo Cradle and Cloudnine have merged, forming a significant platform for maternity and fertility care services, with an estimated worth of INR 1,550 crores. AHLL's Mother & Child, Fertility businesses are part of this deal, and AHLL retains a 9.9% equity stake in the combined entity.

Morgan Stanley maintains a positive outlook for Apollo Hospitals, predicting a potential price of INR 8,833 and suggesting investors consider it as an overweight investment.

The Nifty index has surpassed 23,650 today, with key contributors including Grasim, Indigo, and Apollo Hospitals. Notable gains are being observed in these stocks during the afternoon trading session.

Apollo Hospitals predicts that their Kolkata facility will become profitable within the next year, due to an accelerated growth in operations following its expansion.

Macquarie maintains its optimistic outlook for Apollo Hospitals, raising its price target to ₹6230 following strong Q4 results. The strategic merger with Cloudnine, worth around ₹15.5 billion, is expected to bolster growth opportunities for the company.

Apollo Hospitals exceeded expectations with a 36% increase in Q4 profits year-over-year, resulting in a proposed dividend of ₹10 per share for shareholders.

Apollo Hospitals has announced a proposed dividend of INR 10 per share for the fiscal year 2026, pending approval at the annual general meeting on August 25, 2026. Notably, Rama Bijapurkar and Prathap C. Reddy have been reappointed as Independent Director and Executive Chairman respectively.

Apollo Hospitals reported a profit after tax (PAT) of INR 928.3 crore for FY2026, alongside reserve accumulation of INR 963 crore. The board has decided to distribute a dividend of INR 10 per share, initiated a merger of Apollo North, and agreed to a divestment deal worth INR 1550 crore.

The Nifty index is finding resistance at its 50-day moving average, with the IT sector showing a 6% growth. Pivotal results from companies like Apollo Hospitals, Grasim, BEL, BPCL, and IRB Infra are expected to shape market direction.

Companies like Grasim, Apollo Hospitals, and Bosch are set to release their Q4 FY26 financial results today, joining a total of 123 companies disclosing their earnings for the quarter.

Apollo Hospitals anticipates significant growth in Q4, attributed to additional beds and a surge in Average Revenue Per Patient (ARPP). The healthcare provider expects double-digit revenue increase as a result.

The benchmark GIFT Nifty index has dropped by approximately 165 points to around 23,450, aligning with a general decline in US markets. Meanwhile, Apollo Hospitals and Grasim are set to announce their results today, while banks prepare for increased disclosure requirements.

Apollo Hospitals anticipates a 19% increase in Q2 profits with potential revenue growth of 17%. Grasim's results are also due, while Jubilant Foods, Samvardhana Motherson, and two other futures companies await their turn to announce their financial performance.